Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Safety Profile, Axial Spondyloarthritis

Plenary Presentations - 2021 - International Journal of Rheumatic

Real-world effectiveness of golimumab in adult patients with

Impact of tapering targeted therapies (bDMARDs or JAKis) on the

PDF) Achieving minimal disease activity in psoriatic arthritis

PDF) Recommendations of the French Society for Rheumatology. TNFα

PDF) Effectiveness of switching between TNF inhibitors in patients

PDF) Multi-biomarker disease activity score as a predictor of

Safety Profile, Axial Spondyloarthritis

Disease activity measurements and monitoring in psoriatic